Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for pain in adult chronic nonbacterial osteitis
NL-OMON52471Phase 3Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic nonbacterial osteomyelitis (CRMO), SAPHO syndrome (SAPHO) and sternocostoclavicular hyperostosis (SCCH) comparing Pamidronate with Placebo (2 arms). Primary endpoint: Change in maximal pain score. Started Dec 2020; status: recruiting.
02
Drugs
pamidronate
03
Conditions
Chronic nonbacterial osteomyelitis (CRMO)SAPHO syndrome (SAPHO)sternocostoclavicular hyperostosis (SCCH)
Beyond the preview
Go deeper on NL-OMON52471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52471.